96 related articles for article (PubMed ID: 1534853)
1. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.
Miyazawa M; Nishio J; Chesebro B
J Virol; 1992 Jul; 66(7):4497-507. PubMed ID: 1534853
[TBL] [Abstract][Full Text] [Related]
2. Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept.
Huber G; Bánki Z; Kunert R; Stoiber H
Biomed Res Int; 2014; 2014():971345. PubMed ID: 24524088
[TBL] [Abstract][Full Text] [Related]
3. A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response.
Podschwadt P; Malyshkina A; Windmann S; Werner T; Hansen W; Bayer W
Retrovirology; 2022 Dec; 19(1):29. PubMed ID: 36527061
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
[TBL] [Abstract][Full Text] [Related]
5. Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses.
Littwitz-Salomon E; Schimmer S; Dittmer U
J Virol; 2017 Nov; 91(22):. PubMed ID: 28904191
[TBL] [Abstract][Full Text] [Related]
6. Immunodominance of Adenovirus-Derived CD8
Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
[TBL] [Abstract][Full Text] [Related]
7. Interference of retroviral envelope with vaccine-induced CD8
Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
[TBL] [Abstract][Full Text] [Related]
8. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.
Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W
Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802
[TBL] [Abstract][Full Text] [Related]
9. Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells.
Littwitz-Salomon E; Dittmer U; Sutter K
Retrovirology; 2016 Nov; 13(1):77. PubMed ID: 27821119
[TBL] [Abstract][Full Text] [Related]
10. Mice of the resistant H-2(b) haplotype mount broad CD4(+) T cell responses against 9 distinct Friend virus epitopes.
Messer RJ; Lavender KJ; Hasenkrug KJ
Virology; 2014 May; 456-457():139-44. PubMed ID: 24889233
[TBL] [Abstract][Full Text] [Related]
11. Analysis of two monoclonal antibodies reactive with envelope proteins of murine retroviruses: one pan specific antibody and one specific for Moloney leukemia virus.
Evans LH; Boi S; Malik F; Wehrly K; Peterson KE; Chesebro B
J Virol Methods; 2014 May; 200():47-53. PubMed ID: 24556162
[TBL] [Abstract][Full Text] [Related]
12. Humoral immunity in the Friend retrovirus infection model.
Halemano K; Harper MS; Guo K; Li SX; Heilman KJ; Barrett BS; Santiago ML
Immunol Res; 2013 Mar; 55(1-3):249-60. PubMed ID: 22961660
[TBL] [Abstract][Full Text] [Related]
13. Modification of one epitope-flanking amino acid allows for the induction of friend retrovirus-specific CD8+ T cells by Adenovirus-based immunization.
Gödel P; Windmann S; Dietze KK; Dittmer U; Bayer W
J Virol; 2012 Nov; 86(22):12422-5. PubMed ID: 22933287
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.
Gibbert K; Joedicke JJ; Meryk A; Trilling M; Francois S; Duppach J; Kraft A; Lang KS; Dittmer U
PLoS Pathog; 2012; 8(8):e1002868. PubMed ID: 22912583
[TBL] [Abstract][Full Text] [Related]
15. Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
Lietz R; Bayer W; Ontikatze T; Johrden L; Tenbusch M; Storcksdieck Genannt Bonsmann M; Uberla K; Dittmer U; Wildner O
J Virol; 2012 Feb; 86(3):1706-16. PubMed ID: 22090142
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.
Nair S; Bayer W; Ploquin MJ; Kassiotis G; Hasenkrug KJ; Dittmer U
Retrovirology; 2011 Sep; 8():76. PubMed ID: 21943070
[TBL] [Abstract][Full Text] [Related]
17. Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.
Bayer W; Lietz R; Ontikatze T; Johrden L; Tenbusch M; Nabi G; Schimmer S; Groitl P; Wolf H; Berry CM; Uberla K; Dittmer U; Wildner O
Retrovirology; 2011 Sep; 8():75. PubMed ID: 21943056
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
Bayer W; Tenbusch M; Lietz R; Johrden L; Schimmer S; Uberla K; Dittmer U; Wildner O
J Virol; 2010 Feb; 84(4):1967-76. PubMed ID: 20007267
[TBL] [Abstract][Full Text] [Related]
19. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
